Evidence map›Paper›PMID 16498402›Full record

ArticleThe EMBO journal2006

Bex1, a novel interactor of the p75 neurotrophin receptor, links neurotrophin signaling to the cell cycle.

Marçal Vilar, Maribel Murillo-Carretero, Helena Mira, Kalle Magnusson, Valerie Besset, Carlos F Ibáñez

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Novel netrin-1-Unc5b-Klf4 axis balances AT2 survival in experimental bronchopulmonary dysplasia.American journal of respiratory cell and molecular biology · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. In vivo functions of p75Trends in pharmacological sciences · 2021
    Review
  14. Oncology letters · 2020
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Translating Translation to Mechanisms of Cardiac Hypertrophy.Journal of cardiovascular development and disease · 2020
    Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Marçal VilarDivision of Molecular Neurobiology, Department of Neuroscience, Karolinska Institute, Stockholm, Sweden.
Maribel Murillo-Carretero
Helena Mira
Kalle Magnusson
Valerie Besset
Carlos F Ibáñez
Stockholm University · SEKarolinska Institutet · SEInstitute of Neurobiology · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A screening for intracellular interactors of the p75 neurotrophin receptor (p75NTR) identified brain-expressed X-linked 1 (Bex1), a small adaptor-like protein of unknown function. Bex1 levels oscillated during the cell cycle, and preventing the normal cycling and downregulation of Bex1 in PC12 cells sustained cell proliferation under conditions of growth arrest, and inhibited neuronal differentiation in response to nerve growth factor (NGF). Neuronal differentiation of precursors isolated from the brain subventricular zone was also reduced by ectopic Bex1. In PC12 cells, Bex1 overexpression inhibited the induction of NF-kappaB activity by NGF without affecting activation of Erk1/2 and AKT, while Bex1 knockdown accelerated neuronal differentiation and potentiated NF-kappaB activity in response to NGF. Bex1 competed with RIP2 for binding to the p75NTR intracellular domain, and elevating RIP2 levels restored the ability of cells overexpressing Bex1 to differentiate in response to NGF. Together, these data establish Bex1 as a novel link between neurotrophin signaling, the cell cycle, and neuronal differentiation, and suggest that Bex1 may function by coordinating internal cellular states with the ability of cells to respond to external signals.

Indexed as

Cell CycleActivating Transcription Factor 2AnimalsApoptosis Regulatory ProteinsCarrier ProteinsCell ProliferationHumansKidneyMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nerve Growth FactorNerve Growth FactorsNerve Tissue ProteinsNeuronsNF-kappa BPC12 CellsActivating Transcription Factor 2Apoptosis Regulatory ProteinsBex2 protein, ratBex3 protein, ratCarrier ProteinsMitogen-Activated Protein Kinase 1Mitogen-Activated Protein Kinase 3Nerve Growth FactorNerve Growth FactorsNerve Tissue ProteinsNF-kappa BProtein Serine-Threonine KinasesProto-Oncogene Proteins c-aktReceptor-Interacting Protein Serine-Threonine Kinase 2Receptor, Nerve Growth FactorRIPK2 protein, humanTumor Necrosis Factor Receptor-Associated Peptides and Proteins

Identifiers

PMID16498402
PMCPMC1422154
OpenAlexW2106357844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.